NCT07369505 2026-01-27Sapu003 in Advanced mTOR-sensitive Solid TumorsSAPU NANO (US) LLCPhase 1 Recruiting27 enrolled
NCT02890069 2023-01-11A Study of PDR001 in Combination With LCL161, Everolimus or PanobinostatNovartisPhase 1 Completed298 enrolled